Form D filings with the SEC list David G. Wang as a Director for OrbiMed Asia Partners VI. See sector focus.
Form D filings with the SEC list David G. Wang as a Director for OrbiMed Asia Partners VI. The filings show one offering, OrbiMed Asia Partners VI, L.P., with a total offering amount of $850,000,000. The issuer's address is Shanghai. The SEC industry group for this offering is Pooled Investment Fund.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Shanghai.
Investors like David G. Wang · Full investor directory · Investor access · Company funding database